RCKT ROCKET PHARMACEUTICALS INC Management Changes 8-K Filing 2024 - Board Appointment Rocket Pharmaceuticals appointed Dr. Mikael Dolsten to its Board of Directors, granting him options to purchase 50,533 shares of common stock, with specific vesting schedules. Dr. Dolsten is an experienced pharmaceutical executive currently at Pfizer.Get access to all SEC 8-K filings of the ROCKET PHARMACEUTICALS INC